Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Concentrix Corp Director's Dealing 2023

Mar 3, 2023

31393_dirs_2023-03-03_a9a41192-a6b0-44c9-8382-9fb61f080485.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Concentrix Corp (CNXC)
CIK: 0001803599
Period of Report: 2023-03-01

Reporting Person: POLK DENNIS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-01 Common Stock M 10000 $55.12 Acquired 25507 Direct
2023-03-01 Common Stock S 3791 $135.484 Disposed 21716 Direct
2023-03-01 Common Stock S 5408 $136.729 Disposed 16308 Direct
2023-03-01 Common Stock S 801 $137.33 Disposed 15507 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-01 Employee Stock Option (Right to Buy) $55.12 M 10000 Disposed 2029-10-02 Common Stock (10000.0) Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2021.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.03 to $136.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.04 to $137.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.065 to $137.61, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: This stock option vested as to 20% of the shares on the first anniversary of October 2, 2020 and vests as to 1/60th of the shares monthly thereafter.